|
Florastor®
Safety
Warning
Do not
use Florastor or other probiotics in any ICU setting and in those individuals with open
arterial and venous access required (such as a Vascath, Permcath, or AV fistula). Do not
use for any individual with a central line or port or in the surroundings of any patient
with a central line or port. [Central lines include short- and long-term central venous
catheters (CVCs) and peripherally inserted central catheters (PICCs)]. Do not use
Florastor for pre- or post- organ or bone marrow transplant patients and other patients
considered severely immunocompromised or critically ill. Do not use Florastor probiotics
if allergic to any components (especially yeast). Very rarely, side effects such as:
allergic reaction (skin rash). Fungemia or sepsis in patients with a central venous
catheter, and in hospitalized, immunocompromised patients may occur.
For product questions or to report an adverse event, please call
877-356-7787.
References:
1. More MI, Swidsinski A.
Saccharomyces boulardii CNCM I-745® supports
regeneration of the intestinal microbiota after diarrheic dysbiosis – A review. Clinical
and Experimental Gastroenterology. 2015;8:237-255. doi:10.2147/CEG.S85574.
2. Shan LS et al.
Prevention and treatment of diarrhoea with Saccharomyces boulardii in children
with lower respiratory tract infections. Beneficial Microbes. 2013;4(4):329-334.
doi:10.3920/BM2013.0008.
3. Can M et al.
Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated
diarrhea: A prospective study. Medical Science Monitor. 2006;12(4):2004-2007
4. Neut C, Mahieux S,
Dubreuil LJ. Antibiotic susceptibility of probiotic strains: Is it reasonable to combine
probiotics with antibiotics? Med Mal Infect. 2017 Nov;47(7):477-483. doi:
10.1016/j.medmal.2017.07.001. Epub 2017 Aug 7. PMID: 28797834.
|